Butler John P. - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Mar 3, 2025, Butler John P.'s relationship to Akebia Therapeutics, Inc. (AKBA) is Director,Officer (CEO and President), and currently has 2,557,921 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKBA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Butler John P. - Insider Non-Derivative Transactions of AKBA Common Stock

Butler John P. - Insider Non-Derivative Transactions at AKBA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Mar 4, 2025	Sell -- (Common Stock)	46409	1.83	2557921
Feb 4, 2025	Sell -- (Common Stock)	97982	2.1	2604330
Feb 4, 2025	Sell -- (Common Stock)	46268	2.1	2702312
Feb 1, 2025	Acquisition -- (Common Stock)	701000	0	2748580
Mar 1, 2024	Sell -- (Common Stock)	46570	1.58	2044580
Feb 28, 2024	Sell -- (Common Stock)	37733	1.52	2091150
Feb 2, 2024	Sell -- (Common Stock)	46489	1.68	2128883
Feb 1, 2024	Acquisition -- (Common Stock)	603500	0	2175372
Mar 2, 2023	Sell -- (Common Stock)	6370	0.88	1568872
Mar 2, 2023	Sell -- (Common Stock)	47239	0.88	1575242
Mar 2, 2023	Sell -- (Common Stock)	38259	0.88	1622481
Feb 28, 2023	Sell -- (Common Stock)	38632	0.81	1660740
Feb 1, 2023	Acquisition -- (Common Stock)	293125	0	1699372